GSK Bio
NEWS
If you had a crystal ball, you probably would have invested in Berkshire Hathaway in 1964, or Apple in the 1980s.
Since Emma Walmsley took over leadership at Glaxo, expectations have been both high and hypercritical.
Bexsero is the first vaccine in the world to receive the designation twice.
Companies including Sanofi, J&J, Nestle have dropped out.
Now insiders say J&J has decided it is no longer interested.
KaNDy Therapeutics is a clinical-stage company that is focused on female sex-hormone related conditions.
Narasimhan takes over the role of CEO in February as current CEO Joe Jimenez retires.
The latest funding round gives XtalPi $20M in the bank, which the company said makes it “one of the top-funded AI-powered biotechs.”
Speculation around a possible bid has mounted in recent months.
JOBS
IN THE PRESS